Home › Products › Oncology › Palozest 0.25mg Injection
Palozest 0.25mg Injection
Salt Composition: PALONOSETRON
- Manufacturer: ZEE LABORATORIES LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 0.25MG
- Prescription Required
- Storage: Store Palozest 0.25mg Injection in the original package at room temperature (25°C). Do not freeze. Keep it out of reach from children and pets. It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and reschedule the dose.
₹141.00₹234.38
Inclusive of all taxes
Product Introduction
Palozest 0.25mg Injection is an antiemetic drug belonging to the class of 5-HT3 receptor antagonists, containing the active ingredient Palonosetron. It is used to prevent and treat nausea, vomiting, or sickness caused by cancer treatments such as chemotherapy, radiotherapy, or after surgery. Nausea is characterised by stomach pain and the urge to vomit. The forcible voluntary or involuntary emptying of the stomach's contents through the mouth is known as vomiting. Common side effects that may occur with this medicine include hives, swollen face, breathing trouble and chest pain. Inform your healthcare provider if these side effects concern you or persist for longer than usual. It is administered right away or later with anticancer medicines. It is usually given up to 24 hours while recovering from anaesthesia after surgery. Speak to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals in your blood such as magnesium and potassium. This medicine should not be used if you are allergic to Palozest 0.25mg Injection. Inform your physician about all the medications you are taking recently, including herbal medicines and supplements, before taking Palonosetron.
Uses
Palozest 0.25mg Injection is a prescription medicine, and it is used to treat Postoperative nausea and vomiting. Chemotherapy induced nausea and vomiting.
How it works
Palonosetron is an Isoquinoline derivative that interacts with 5-HT3 receptor antagonists. It is a type of serotonin receptor antagonist, which works by blocking the action of serotonin in the body that induces nausea and vomiting. They are also effective in the prevention and treatment of nausea and vomiting in patients undergoing radiation therapy to the whole body or abdomen.
How to Use
The medicine will be administered to you by a qualified healthcare professional in a hospital setting. This injection will be given intravenously into a vein in your arm or hand. Do not self-administer this medicine. The dose of the injection will be decided by your doctor based on your disease condition and other factors. Palozest 0.25mg Injection is usually given about 30 minutes before you receive your anti-cancer medicine (chemotherapy) or right before anaesthesia for surgery. If you are taking palonosetron as an oral tablet, it should be swallowed whole with a glass of water, with or without food, as directed by your healthcare provider. Do not crush, chew, or break the tablet before swallowing it.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common: Headache Fatigue Dizziness Abdominal pain. Serious: Allergic reactions Hives Swollen face Breathing trouble Chest pain
Expert Tips
Talk to your physician if you have a history of repeated constipation, blockage in the bowel, heart problems, or imbalance of certain minerals (such as potassium and magnesium) in your blood before taking Palozest 0.25mg Injection. Inform your doctor or nurse if you are taking any medicines that affect your heart beat because they could cause a heart beat problem when taken with Palonosetron solution for injection.
References
- Accord Healthcare SLU, Electronic medicines compendium (emc), [Revised on Feb 2021] [ Accessed on 01st March 2023], https://www.medicines.org.uk/emc/files/pil.7235.pdf
- Fresenius kabi, US Food and Drug Administration, [Revised on Dec 2018] [Accessed on 01st March 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208109s001lbl.pdf
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Treatment of disorders of bowel motility and water flux, 12th edition, 2011, 1341.
- KD Tripathi, Essentials of Medical Pharmacology, Antiemetic, prokinetic and digestant drugs, 7th edition, 2013, 669.
Safety Advice
Pregnancy: unsafe It is unknown whether Palozest 0.25mg Injection can be administered during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Lungs: Consult your doctor It is unknown whether Palozest 0.25mg Injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Breastfeeding: Consult your doctor It is unsafe to breastfeed during the treatment with this injection because it may cause harm to the baby. Please consult your doctor before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.